Pharma-Bio Serv (OTCQB:PBSV) reported approximately $2.3 million in revenue for the quarter ended July 31, 2026, up approximately $0.4 million from the prior-year period. The company posted a net loss of $14,000 for the quarter.
For the nine months ended July 31, Pharma-Bio Serv reported approximately $7.3 million in revenue and net income of approximately $252,000.
- Quarterly revenue was approximately $2.3 million.
- Quarterly net loss was $14,000, an improvement of approximately $190,000 from the corresponding prior-year period.
- Nine-month revenue increased approximately $0.5 million from the prior-year period.
- Nine-month net income was approximately $252,000, an improvement of approximately $352,000 year over year.
